ArticleCurrent oncology (Toronto, Ont.)2024
Doxycycline Plus Bortezomib-Containing Regimens for the Treatment of Light-Chain Amyloidosis in the Frontline Setting: Experience from the Amyloidosis Program of Calgary.
Ellen Lewis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.